CAS 35922-06-6

Tetradecanamide,N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-

Description:

Tetradecanamide, N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]- is an organic compound characterized by its amide functional group, which is derived from tetradecanoic acid (a long-chain fatty acid) and a specific chiral amine. This compound features a tetradecyl chain, contributing to its hydrophobic properties, while the presence of a hydroxyl group and a nitrophenyl moiety introduces polar characteristics, enhancing its solubility in polar solvents. The stereochemistry indicated by the (1R,2R) configuration suggests specific spatial arrangements that can influence the compound's biological activity and interactions. The nitrophenyl group may impart additional reactivity and potential applications in pharmaceuticals or as a biochemical probe. Overall, this compound's unique structure combines hydrophobic and hydrophilic elements, making it of interest in various chemical and biological contexts, including potential uses in drug formulation or as a surfactant.

Formula: C₂₃H₃₈N₂O₅

Synonyms:

• Tetradecanamide,N-[2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-, [R-(R*,R*)]-

D-NMAPPD

CAS: 35922-06-6

Litifilimab (BIIB059) is a humanized antibody targeting BDCA2 and CLEC4C for the study of cutaneous lupus erythematosus.

Formula: C₂₃H₃₈N₂O₅

Color and Shape: Solid

Molecular weight: 422.56

Ref: TM-T22069